Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnicorn Asset Management Regulatory News (UAV)

Share Price Information for Unicorn Asset Management (UAV)

Share Price is delayed by 15 minutes
Get Live Data
70.00    0.00 (0.00%)
Bid:
67.00
Ask:
73.00
Spread: 6.00 (8.955%)
Market Cap: £180.27m
UAV Live PriceLast checked at - London Stock Exchange

Intraday Unicorn Asset Management Share Chart

Dividend Declaration

15 Jan 2026 15:57

RNS Number : 1226P
Unicorn AIM VCT PLC
15 January 2026
 

Unicorn AIM VCT PLC (the "Company")

LEI: 21380057QDV7D34E9870

Announcement of Special Dividend

 

The Company announced on 28 November 2025 that Hasgrove Ltd ("Hasgrove") had been acquired by Castik Capital S.à r.l. ("Castik") and that the Company's final share of the proceeds was £88m. £22m of these proceeds were invested alongside funds managed by Castik, the Executive Team, and the former Chair of Hasgrove in Maia TopCo Ltd, the new company formed to acquire Hasgrove to enable Unicorn AIM VCT plc. to continue to participate in the future growth of Hasgrove. The remaining £66m was received in cash.

Tim Woodcock, Chair, Unicorn AIM VCT plc. Commented at the time:

"The Unicorn team have delivered an excellent result in both realising considerable cash proceeds from the investment for the Company's shareholders, and negotiating a deal which enables the VCT to participate in the future growth of Hasgrove"

The Directors of the Company have now resolved to distribute £50m of the gains to Shareholders following the disposal. As a result, the Directors have declared a Special Dividend of 23.0p per ordinary share.

The dividend will be paid on 5 March 2026 to Shareholders on the register on 23 January 2026 and the shares will be quoted ex-dividend* on 22 January 2026.

Further to the announcement released on 27 November 2025 of the intention to launch an Offer for subscription and following the change in the VCT rules in the Budget, including the reduction in the tax credit on new subscriptions from 30% to 20% in the tax years commencing on and from 6 April 2026, the Board has decided to increase the size of the Offer for subscription to raise £20 million (with an over-allotment facility to raise up to a further £15 million) through the issue of new ordinary shares. Full details of the Offer are expected to be published in late January 2026. 

Shareholders are reminded that, should they wish to reinvest their dividends into new shares in the Company, the Dividend Reinvestment Scheme ("DRIS") is open to all Shareholders to join, and new shares issued should, subject to an individual shareholder's personal circumstances, attract the 30% tax credit given on new investment. Details on how to join the DRIS can be found on the Company's website: https://unicornaimvct.co.uk/dividend-reinvestment-scheme/.

The Board will continue to consider the payment in the future of a further special dividend relating to the balance of the proceeds from the disposal of Hasgrove shares, subject to prevailing circumstances and market conditions.

 

* Shares acquired on or after the ex-dividend date will not qualify for the dividend

 

For further information, please contact:

ISCA Administration Services Limited (the Company Secretary) on

01392 487056; or unicornaimvct@iscaadmin.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVEASFSFSSKEFA
Date   Source Headline
1st Apr 202510:07 amRNSTotal Voting Rights
31st Mar 202511:15 amRNSOffer for Subscription - Update
18th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 202512:04 pmRNSOffer Update - Overallotment
11th Mar 20251:01 pmRNSDirector/PDMR Shareholding
11th Mar 202511:15 amRNSIssue of Equity under Offer
6th Mar 202511:14 amRNSNet Asset Value(s)
3rd Mar 202510:05 amRNSTotal Voting Rights
21st Feb 20257:00 amRNSDirector/PDMR Shareholding
21st Feb 20257:00 amRNSIssue of Equity
12th Feb 20251:27 pmRNSResult of AGM
4th Feb 20252:39 pmRNSNet Asset Value(s)
3rd Feb 202510:15 amRNSTotal Voting Rights
28th Jan 202512:14 pmRNSPublication of a Prospectus
17th Jan 20256:01 pmRNSTransaction in Own Shares
10th Jan 20253:31 pmRNSNet Asset Value(s)
2nd Jan 202512:51 pmRNSDirector Declaration
2nd Jan 20257:00 amRNSTotal Voting Rights
17th Dec 20244:18 pmRNSTransaction in Own Shares
9th Dec 20242:17 pmRNSNet Asset Value(s)
6th Dec 20247:00 amRNSFinal Results
29th Nov 202411:59 amRNSDividend Declaration
27th Nov 20247:00 amRNSINTENTION TO LAUNCH AN OFFER
5th Nov 20243:05 pmRNSNet Asset Value(s)
18th Oct 202411:05 amRNSNet Asset Value(s)
2nd Oct 202410:30 amRNSDirectorate Change
1st Oct 20249:45 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSTransaction in Own Shares
9th Sep 20249:56 amRNSNet Asset Value(s)
2nd Sep 202410:02 amRNSTotal Voting Rights
16th Aug 20248:58 amRNSTransaction in Own Shares
13th Aug 20249:38 amRNSDirector/PDMR Shareholding
13th Aug 20249:16 amRNSIssue of Equity
6th Aug 20249:31 amRNSNet Asset Value(s)
8th Jul 20242:00 pmRNSNet Asset Value(s)
1st Jul 202410:12 amRNSTotal Voting Rights
20th Jun 20242:25 pmRNSTransaction in Own Shares
7th Jun 20247:00 amRNSNet Asset Value(s)
23rd May 20247:00 amRNSHalf-year Report
8th May 20249:47 amRNSNet Asset Value(s)
8th Apr 20241:46 pmRNSNet Asset Value(s)
2nd Apr 202410:46 amRNSTotal Voting Rights
18th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 202412:00 pmRNSDirector/PDMR Shareholding
11th Mar 202411:59 amRNSTotal Voting Rights
11th Mar 202411:57 amRNSIssue of Equity
7th Mar 202411:34 amRNSNet Asset Value(s)
1st Mar 202410:54 amRNSTotal Voting Rights
15th Feb 20244:30 pmRNSOffer for Subscription Update
14th Feb 20241:36 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.